Operating
Change in receivables
Bristol-Myers Squibb Change in receivables increased by 100.0% to $0.00 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 100.0%, from -$143.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Change in receivables shows a downward trend with a -26.1% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryEfficiency
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Significant fluctuations often reflect changes in supply chain financing arrangements or timing of payments from manufacturing partners.
Detailed definition
This broader metric includes changes in trade accounts receivable as well as other non-trade receivables, such as vendor...
Peer comparison
In complex global supply chains, this metric often fluctuates based on the timing of component purchasing and vendor rebates.
Metric ID:
cf_change_in_receivablesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $693.00M | $260.00M | $168.00M | -$786.00M | $669.00M | $674.00M | $106.00M | $175.00M | $65.00M | $247.00M | $508.00M | -$479.00M | $1.02B | -$661.00M | -$143.00M | -$15.00M | $484.00M | -$155.00M | $0.00 |
| QoQ Change | — | -62.5% | -35.4% | -567.9% | +185.1% | +0.7% | -84.3% | +65.1% | -62.9% | +280.0% | +105.7% | -194.3% | +312.7% | -164.9% | +78.4% | +89.5% | >999% | -132.0% | +100.0% |
| YoY Change | — | — | — | — | -3.5% | +159.2% | -36.9% | +122.3% | -90.3% | -63.4% | +379.2% | -373.7% | >999% | -367.6% | -128.1% | +96.9% | -52.5% | +76.6% | +100.0% |
Range-$786.00M – $1.02B
CAGR-100.0%
Avg YoY Growth+85.7%
Median YoY Growth-3.5%
Change in receivables at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's change in receivables?
- Bristol-Myers Squibb (BMY) reported change in receivables of $0.00 in Q4 2025.
- How has Bristol-Myers Squibb's change in receivables changed year-over-year?
- Bristol-Myers Squibb's change in receivables increased by 100.0% year-over-year, from -$143.00M to $0.00.
- What is the long-term trend for Bristol-Myers Squibb's change in receivables?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's change in receivables has grown at a -26.1% compound annual growth rate (CAGR), from $1.05B to $314.00M.
- What does change in receivables mean?
- The total change in all money owed to the company from both customers and other partners.